Widespread ischemic brain lesions caused by vasculopathy associated with neurofibromatosis type 1

Neuropathology

Volumn 30, Issue 6, 2010, Pages 627-633

  Okazaki, Kenichi ^a   Kakita, Akiyoshi ^a   Tanaka, Hajime ^b   Kimura, Kakuhei ^b   Minagawa, Makoto ^b   Morita, Takashi ^b   Takahashi, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Shinrakuen Hospital   (Japan)

Author keywords

Cerebral infarcts; Cerebrovasculopathy; Neurofibromin; NF1 vasculopathy; Stroke

Indexed keywords

NEUROFIBROMIN; SMOOTH MUSCLE ACTIN; VIMENTIN;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN ATROPHY; BRAIN ISCHEMIA; CASE REPORT; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DISEASE ASSOCIATION; EPILEPTIC STATE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VASCULAR DISEASE;

ADULT; BLOTTING, WESTERN; BRAIN; BRAIN ISCHEMIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEUROFIBROMATOSIS 1; YOUNG ADULT;

EID: 78649593522     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2009.01097.x     Document Type: Article

References (23)

1. Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004; 17: 101-105.
2. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 2007; 6: 340-351.
3. Friedman JM, Gutmann DH, MacCollin M, Riccardi VM. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd edn. Baltimore: Johns Hopkins University Press, 1999.
4. Créange A, Zeller J, Rostaing-Rigattieri S et al. Neurological complications of neurofibromatosis type 1 in adulthood. Brain 1999; 122: 473-481.
5. Friedman JM, Arbiser J, Epstein JA et al. Cardiovascular disease in neurofibromatosis 1: report of the NF1 cardiovascular task force. Genet Med 2002; 4: 105-111.
6. Hamilton SJ, Friedman JM. Insights into pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet 2000; 58: 341-344.
7. Oderich GS, Sullivan TM, Bower TC et al. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg 2007; 46: 475-484.
8. Lin AE, Birch P, Korf BR et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis type 1. Am J Med Genet 2000; 95: 108-117.
9. Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 2005; 64: 553-555.
10. Sobata E, Ohkuma H, Suzuki S. Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis: a case report. Neurosurgery 1988; 22: 544-549.
11. Tang S-C, Lee M-J, Jeng J-S, Yip P-K. Novel mutation of neurofibromatosis type 1 in a patient with cerebral vasculopathy and fatal ischemic stroke. J Neurol Sci 2006; 243: 53-55.
12. Norton KK, Xu J, Gutmann DH. Expression of the neurofibromatosis 1 gene product, neurofibromin, in the blood vessel endothelial cells and smooth muscle. Neurobiol Dis 1995; 2: 13-21.
13. Riccardi VM. The vasculopathy of NF1 and histogenesis control genes. Clin Genet 2000; 58: 345-347.
14. Riccardi VM. Histogenesis control genes and neurofibromatosis 1. Eur J Pediatr 2000; 159: 475-476.
15. Xu J, Ismat FA, Wang T, Yang J, Epstein JA. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response. Circulation 2007; 116: 2148-2156.
16. Lasater EA, Bessler WK, Mead LE et al. NF1+/- mice have increased neointima formation wia hyperactivation of a Gleevec sensitive molecular pathway. Hum Mol Genet 2008; 17: 2336-2344.
17. Ghadially FN. Intracytoplasmic filaments. In: Ghadially FN, ed. Ultrastructural Pathology of the Cell and Matrix, Vol. 2, 3rd edn. London: Butterworths, 1988; 839-936.
18. Lehrnbecher T, Gassel AM, Rauh V, Kirchner T, Huppertz H-I. Neurofibromatosis presenting as a severe systemic vasculopathy. Eur J Pediatr 1994; 153: 107-109.
19. Bognanno JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Klatte EC. Cranial MR imaging in neurofibromatosis. Am J Roentgenol 1988; 151: 381-388.
20. Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989; 39: 373-378.
21. Sevick RJ, Barkovich AJ, Edwards MS, Koch T, Berg B, Lempert T. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 1992; 159: 171-175.
22. Ullrich NJ, Raja AL, Irons MB, Kieran MW, Goumnerova L. Brainstem lesions in neurofibromatosis type 1. Neurosurgery 2007; 61: 762-767.
23. Yokota O, Tsuchiya K, Hayashi M et al. Glial clusters and perineuronal glial satellitosis in the basal ganglia of neurofibromatosis type 1. Acta Neuropathol 2008; 116: 57-66.